CRISPR in cancer biology and therapy

A Katti, BJ Diaz, CM Caragine, NE Sanjana… - Nature Reviews …, 2022 - nature.com
Over the past decade, CRISPR has become as much a verb as it is an acronym,
transforming biomedical research and providing entirely new approaches for dissecting all …

Patient-derived organoids in precision medicine: drug screening, organoid-on-a-chip and living organoid biobank

Z Zhou, L Cong, X Cong - Frontiers in Oncology, 2021 - frontiersin.org
Organoids are in vitro self-assembling, organ-like, three-dimensional cellular structures that
stably retain key characteristics of the respective organs. Organoids can be generated from …

Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer

V Kumar, K Ramnarayanan, R Sundar… - Cancer discovery, 2022 - AACR
Gastric cancer heterogeneity represents a barrier to disease management. We generated a
comprehensive single-cell atlas of gastric cancer (> 200,000 cells) comprising 48 samples …

Cancer spheroids and organoids as novel tools for research and therapy: state of the art and challenges to guide precision medicine

S El Harane, B Zidi, N El Harane, KH Krause, T Matthes… - Cells, 2023 - mdpi.com
Spheroids and organoids are important novel players in medical and life science research.
They are gradually replacing two-dimensional (2D) cell cultures. Indeed, three-dimensional …

[HTML][HTML] Promises and challenges of organoid-guided precision medicine

S Bose, H Clevers, X Shen - Med, 2021 - cell.com
Organoids are self-organizing, expanding 3D cultures derived from stem cells. Using tissue
derived from patients, these miniaturized models recapitulate various aspects of patient …

The role of organoids in cancer research

Z Fang, P Li, F Du, L Shang, L Li - Experimental Hematology & Oncology, 2023 - Springer
Organoids are established through in vitro 3D culture, and they can mimic the structure and
physiological functions of organs or tissues in vivo. Organoids have attracted much attention …

Organoids in gastrointestinal diseases: from experimental models to clinical translation

C Günther, B Winner, MF Neurath, TS Stappenbeck - Gut, 2022 - gut.bmj.com
We are entering an era of medicine where increasingly sophisticated data will be obtained
from patients to determine proper diagnosis, predict outcomes and direct therapies. We …

Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1

Z Feng, ME Hom, TE Bearrood, ZC Rosenthal… - Nature chemical …, 2022 - nature.com
Aldehyde dehydrogenases (ALDHs) are promising cancer drug targets, as certain isoforms
are required for the survival of stem-like tumor cells. We have discovered selective inhibitors …

Flourishing tumor organoids: History, emerging technology, and application

Q Yang, M Li, X Yang, Z Xiao, X Tong… - Bioengineering & …, 2023 - Wiley Online Library
Malignant tumors are one of the leading causes of death which impose an increasingly
heavy burden on all countries. Therefore, the establishment of research models that closely …

[HTML][HTML] Deterministic evolution and stringent selection during preneoplasia

K Karlsson, MJ Przybilla, E Kotler, A Khan, H Xu… - Nature, 2023 - nature.com
The earliest events during human tumour initiation, although poorly characterized, may hold
clues to malignancy detection and prevention. Here we model occult preneoplasia by …